E11.349
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
Type 2 diabetes mellitus is a chronic condition that affects how the body processes blood sugar (glucose). When blood sugar levels are not well controlled, it can lead to various complications, including eye problems such as diabetic retinopathy. The ICD-10 code E11.349 specifically refers to a case of type 2 diabetes with severe nonproliferative diabetic retinopathy (NPDR) without macular edema. This condition involves damage to the small blood vessels in the retina, contributing to vision problems if left unmanaged. Although it is severe, the absence of macular edema means swelling in the central part of the retina (macula) has not yet occurred.
Causes & Symptoms
Clinical Causes: Persistent high blood sugar levels over a long period Poor blood sugar control or management High blood pressure and lipid levels contributing to vascular damage Duration of diabetes—longer duration increases risk Lifestyle factors such as smoking, poor diet, and physical inactivity
Key Symptoms: Blurred vision Sudden vision changes or reduced clarity Visual floaters or spots Difficulty seeing in dim lighting No pain or discomfort until advanced stages Potential progression to more severe forms of retinopathy if untreated
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination by an ophthalmologist or optometrist, including retinal imaging techniques such as dilated fundus examination, optical coherence tomography (OCT), or fluorescein angiography. These tests help identify the presence and severity of diabetic retinopathy and evaluate the extent of blood vessel damage in the retina. Regular screening is vital for early detection and management of diabetic retinopathy in individuals with diabetes.
Treatment Protocols: Strict blood sugar control to prevent further vascular damage Blood pressure and cholesterol management Laser therapy (focal or scatter photocoagulation) to stop or slow bleeding and leakage in the retina Intravitreal injections of medications that inhibit abnormal blood vessel growth or reduce inflammation Regular monitoring and eye exams to assess disease progression Addressing any other health issues that could contribute to worsening retinopathy
Clinical Advice & FAQs
Billing Guidance
Is E11.349 a billable ICD-10 code?
Yes, E11.349 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E11.349?
Clinical documentation must specify the nature of Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference